News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
319,164 Results
Type
Article (18778)
Company Profile (37)
Press Release (300348)
Multimedia
Podcasts (13)
Webinars (3)
Section
Business (87869)
Career Advice (1070)
Deals (16312)
Drug Delivery (29)
Drug Development (46164)
Employer Resources (25)
FDA (7679)
Job Trends (6772)
News (157465)
Policy (12896)
Tag
Academia (785)
Accelerated approval (9)
Adcomms (9)
Allergies (56)
Alliances (16747)
ALS (67)
Alzheimer's disease (649)
Antibody-drug conjugate (ADC) (99)
Approvals (7854)
Artificial intelligence (106)
Autoimmune disease (36)
Automation (5)
Bankruptcy (139)
Best Places to Work (5436)
BIOSECURE Act (6)
Biosimilars (72)
Biotechnology (21)
Bladder cancer (98)
Brain cancer (23)
Breast cancer (290)
Cancer (2102)
Cardiovascular disease (171)
Career advice (921)
Career pathing (7)
CAR-T (85)
CDC (11)
Cell therapy (277)
Cervical cancer (20)
Clinical research (39932)
Collaboration (396)
Compensation (382)
Complete response letters (18)
COVID-19 (1237)
CRISPR (24)
C-suite (116)
Cystic fibrosis (50)
Data (2908)
Denatured (1)
Depression (46)
Diabetes (229)
Diagnostics (2365)
Digital health (13)
Diversity (1)
Diversity, equity & inclusion (5)
Drug discovery (55)
Drug pricing (37)
Drug shortages (7)
Duchenne muscular dystrophy (100)
Earnings (54400)
Editorial (12)
Employer branding (5)
Employer resources (21)
Events (51840)
Executive appointments (215)
FDA (9045)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (3)
Frontotemporal dementia (7)
Funding (384)
Gene editing (70)
Generative AI (7)
Gene therapy (219)
GLP-1 (424)
Government (1621)
Grass and pollen (3)
Guidances (320)
Healthcare (7476)
HIV (31)
Huntington's disease (19)
IgA nephropathy (34)
Immunology and inflammation (112)
Immuno-oncology (7)
Indications (30)
Infectious disease (1330)
Inflammatory bowel disease (85)
Inflation Reduction Act (1)
Influenza (33)
Intellectual property (76)
Interviews (249)
IPO (9112)
IRA (8)
Job creations (1597)
Job search strategy (678)
Kidney cancer (9)
Labor market (32)
Layoffs (195)
Leadership (4)
Legal (2551)
Liver cancer (33)
Longevity (3)
Lung cancer (316)
Lymphoma (171)
Machine learning (6)
Management (4)
Manufacturing (176)
MASH (82)
Medical device (5172)
Medtech (5176)
Mergers & acquisitions (7556)
Metabolic disorders (545)
Multiple sclerosis (85)
NASH (5)
Neurodegenerative disease (90)
Neuropsychiatric disorders (26)
Neuroscience (1142)
NextGen: Class of 2025 (2125)
Non-profit (1446)
Now hiring (11)
Obesity (239)
Opinion (71)
Ovarian cancer (88)
Pain (60)
Pancreatic cancer (96)
Parkinson's disease (113)
Partnered (7)
Patents (186)
Patient recruitment (145)
Peanut (26)
People (16024)
Pharmaceutical (11)
Pharmacy benefit managers (3)
Phase I (11892)
Phase II (18255)
Phase III (13715)
Pipeline (1874)
Policy (48)
Postmarket research (1512)
Preclinical (4138)
Press Release (10)
Prostate cancer (91)
Psychedelics (25)
Radiopharmaceuticals (98)
Rare diseases (292)
Real estate (2016)
Recruiting (12)
Regulatory (10301)
Reports (25)
Research institute (743)
Resumes & cover letters (185)
Rett syndrome (14)
RNA editing (5)
RSV (27)
Schizophrenia (80)
Series A (51)
Series B (46)
Service/supplier (3)
Sickle cell disease (53)
Special edition (11)
Spinal muscular atrophy (97)
Sponsored (13)
Startups (1125)
State (1)
Stomach cancer (6)
Supply chain (25)
Tariffs (22)
The Weekly (12)
Vaccines (423)
Venture capital (24)
Weight loss (147)
Women's health (25)
Worklife (6)
Date
Today (71)
Last 7 days (321)
Last 30 days (1168)
Last 365 days (15285)
2025 (11881)
2024 (16816)
2023 (17989)
2022 (25401)
2021 (26221)
2020 (23890)
2019 (18329)
2018 (12984)
2017 (12135)
2016 (10755)
2015 (13606)
2014 (9628)
2013 (6925)
2012 (7688)
2011 (22245)
2010 (39350)
Location
Africa (279)
Alabama (22)
Alaska (1)
Arizona (89)
Arkansas (2)
Asia (18857)
Australia (2939)
California (4378)
Canada (1289)
China (448)
Colorado (158)
Connecticut (204)
Delaware (148)
Europe (44913)
Florida (532)
Georgia (163)
Idaho (20)
Illinois (300)
India (27)
Indiana (233)
Iowa (5)
Japan (196)
Kansas (46)
Kentucky (11)
Louisiana (10)
Maine (36)
Maryland (540)
Massachusetts (3189)
Michigan (89)
Minnesota (230)
Mississippi (2)
Missouri (43)
Montana (9)
Nebraska (3)
Nevada (46)
New Hampshire (41)
New Jersey (1399)
New Mexico (2)
New York (1315)
North Carolina (612)
Northern California (2107)
Ohio (103)
Oklahoma (2)
Oregon (6)
Pennsylvania (917)
Puerto Rico (5)
Rhode Island (8)
South America (463)
South Carolina (11)
Southern California (1711)
Tennessee (33)
Texas (591)
United States (15613)
Utah (102)
Virginia (67)
Washington D.C. (21)
Washington State (314)
West Virginia (2)
Wisconsin (20)
319,164 Results for "12".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Career Advice
The Top 12 Companies Hiring in Biopharma Now
Looking for a biopharma job? Check out the
BioSpace
list of 12 top companies hiring life sciences professionals like you.
October 2, 2025
·
1 min read
·
Angela Gabriel
Press Releases
Aurion Biotech Achieves All Primary, Secondary, and Exploratory Endpoints in AURN001 Phase 1/2 CLARA Trial at 12 Months
October 19, 2025
·
4 min read
M&A
Novartis To ‘Bolster’ Neuromuscular Pipeline With $12B Avidity Acquisition
The deal, announced early Sunday afternoon, will see Novartis gain access to Avidity’s neuroscience assets, while the San Diego biotech spins out a new company to shepherd its early-stage precision cardiology programs.
October 26, 2025
·
2 min read
·
Heather McKenzie
Press Releases
Verastem Oncology Announces Encouraging Preliminary Data from Ongoing Phase 1/2a Dose Escalation Trial of VS-7375, an Oral KRAS G12D (ON/OFF) Inhibitor, in Patients with KRAS G12D Mutant Solid Tumors
October 23, 2025
·
9 min read
Rare diseases
Dyne Primed for Suitors Amid Novartis’ $12B Avidity Acquisition
The takeover of its competitor, announced Sunday, could also bring some attention to Dyne Therapeutics, which has a similar RNA-based pipeline in rare muscle diseases.
October 27, 2025
·
2 min read
·
Tristan Manalac
Press Releases
Heartflow to Report Third Quarter 2025 Financial Results on November 12, 2025
October 23, 2025
·
2 min read
Press Releases
Revolution Medicines to Present Updated Elironrasib Safety and Efficacy Data in Patients with KRAS G12C Non-Small Cell Lung Cancer Following Treatment with a KRAS(OFF) G12C Inhibitor
October 22, 2025
·
7 min read
Press Releases
Recordati Launches 12th Edition of Arrigo Recordati Prize to Support Research in Paediatric Oncology
October 22, 2025
·
3 min read
Press Releases
Corbus Pharmaceuticals to Present CRB-701 Phase 1/2 Data at ESMO 2025
October 15, 2025
·
4 min read
Press Releases
Verastem Oncology Announces Updated Data from Partner GenFleet Therapeutics’ Phase 1/2 Monotherapy Study in China of GFH375 (VS-7375) in Advanced KRAS G12D Mutant Pancreatic Ductal Adenocarcinoma
October 19, 2025
·
9 min read
1 of 31,917
Next
